Prof. Dr. Richard F Schlenk
2 clinical trials · Sponsor
◉ Watch Prof. Dr. Richard F Schlenk
| Record | Firm | Date |
|---|---|---|
| Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD (NCT03989713) | Prof. Dr. Richard F Schlenk | 2020-07-17 |
| The Sarcoma Biology and Outcome Project (NCT04758325) | Prof. Dr. Richard F Schlenk | 2019-07-23 |
Track Prof. Dr. Richard F Schlenk automatically
Every clearance here is in the API, with alerts when new ones post.